GlassScriptPhysician profile
Nicholas J Welle
NPI 1235598897
$6,629.73
in general payments reported to CMS, 2019-2025
20 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.24 · 2022: $2,042 · 2023: $3,792 · 2024: $447 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,278 · Travel and Lodging: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,278.04 |
| Travel and Lodging | $796.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,563.63 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $2,025.57 | 2022-2024 | Progrip |
| Tela Bio, INC. | $209.67 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mimedx Group, INC. | $106.01 | 2024-2025 | |
| Acera Surgical, INC. | $88.24 | 2023-2024 | Restrata Wound Matrix |
| Becton, Dickinson and Company | $64.63 | 2024 | Phasix Mesh |
| Smith+Nephew, INC. | $63.84 | 2023-2024 | Oasis |
| Kerecis Limited | $63.49 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Melinta Therapeutics, LLC | $61.73 | 2024-2025 | Kimyrsa, Orbactiv |
| W. L. Gore & Associates, INC. | $54.25 | 2024-2025 | Gore Synecor Preperitoneal Biomaterial, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Polynovo North America LLC | $50.43 | 2024 | Novosorb Btm |
| Aroa Biosurgery Incorporated | $48.35 | 2024-2025 | |
| Teleflex LLC | $46.79 | 2025 | Quikclot |
| Integra Lifesciences Corporation | $45.53 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Lemaitre Vascular, INC. | $37.00 | 2024 | Trivex System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $31.26 | 2022 | |
| Solventum Corporation | $20.96 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, V.A.C. Granufoam |
| Access Pro Medical, LLC | $18.22 | 2025 | Matriderm |
| Surgenex LLC | $16.89 | 2025 | Pellograft, Ardeograft, Surgraft |
| Boston Scientific Corporation | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Welle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.